Personalized management of cirrhosis by non-invasive tests of liver fibrosis.
10.3350/cmh.2015.21.3.200
- Author:
Grace Lai Hung WONG
1
;
Wendell Zaragoza ESPINOSA
;
Vicnent Wai Sun WONG
Author Information
1. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. wongv@cuhk.edu.hk
- Publication Type:Review
- Keywords:
Transient elastography;
FibroScan;
FibroTest;
Hepatocellular carcinoma;
Varices
- MeSH:
Biomarkers/blood;
Carcinoma, Hepatocellular/diagnosis;
*Elasticity Imaging Techniques;
Endoscopy, Digestive System;
Humans;
Hypertension, Portal/complications;
Liver Cirrhosis/complications/*diagnosis;
Liver Neoplasms/diagnosis;
Risk Factors
- From:Clinical and Molecular Hepatology
2015;21(3):200-211
- CountryRepublic of Korea
- Language:English
-
Abstract:
Owing to the high prevalence of various chronic liver diseases, cirrhosis is one of the leading causes of morbidity and mortality worldwide. In recent years, the development of non-invasive tests of fibrosis allows accurate diagnosis of cirrhosis and reduces the need for liver biopsy. In this review, we discuss the application of these non-invasive tests beyond the diagnosis of cirrhosis. In particular, their role in the selection of patients for hepatocellular carcinoma surveillance and varices screening is highlighted.
